$TGTX Brean Capital Raises TG Therapeutics Price Target To $22 Following Licensing Of Full TGR-1202 Rights http://www.smarteranalyst.com/2014/09/25/brean-capital-raises-tg-therapeutics-price-target-to-22-following-licensing-of-full-tgr-1202-rights/